SARS-CoV-2

Category

Zagazig University Randomized Controlled Ivermectin Study Results Confirms PI Hypothesis: Drug Effective Against COVID-19

A principal investor from Zagazig University, Dr. Waheed Shouman, recently completed a randomized, open label, interventional trial titled “Use of Ivermectin as Prophylactic Option in Asymptomatic Family Close Contact for Patient with COVID-19.” Targeting 340...

Remdesivir Use in Multi-National Clinical Trial of Patients with Moderate COVID-19 & Pneumonia: Perplexing Results

Remdesivir is the only therapy in the United States approved, under emergency use status, as a treatment for COVID-19 along with the just announced convalescent plasma. Referred to as not a ‘knockout drug’ by Dr. Anthony Fauci, Director of the National Institutes of...

Masonic Medical Research Institute Investigating the Connections of COVID-19 to Cardiovascular Conditions

Masonic Medical Research Institute in Utica, New York, now investigates the cardiovascular implications of COVID-19. Led by Dr. Nathan Tucker, Assistant Professor, the research operation sought to better understand why at least some patients infected with SARS-CoV-2,...

Pin It on Pinterest